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with and without the application of botulinum toxin 
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Summary
One of the most common diseases of the nervous system is stroke. Its most frequently occuring kinetic symptoms are paresis or paral-
ysis accompanied by an increase in muscular tension called spasticity. For patients and their carers these disturbances become a prob-
lem in many aspects of their everyday life, especially in locomotion. New ways need to be looked for to create therapies that could 
decrease or remove spasticity and restore the function which was disrupted. Therapy by botulinum toxin has been used as a meth-
od of decreasing spasticity to treat children with cerebral palsy having equines-varus foot, and it proves to be a breakthrough in the 
treatment of diseases with increased muscular tension. Owing to it, a range of mobility increases, for example in an ankle and knee 
joints, which facilitates locomotion. This improvement is caused by both pharmacological action, and assisted kinesitherapy. Propro-
ceptive Neuromuscular Facilitation (PNF) is considered to be especially effective rehabilitation method based on neuro-physiological 
mechanisms. This method in the therapy of adults, along with the application of botulinum toxin, seems to facilitate physical activity 
of the patient after stroke, which may be very important for secondary stroke prevention. The aim of the research was to assess the 
influence of the therapy by PNF method associated with a botulinum toxin application on the patients after stroke with spasticity in 
lower limbs. During gait the patients had the flexion of ankle and knee joints measured by means of VICON system with the special 
focus on the amplitude of angular values. All patients presented in this description of cases showed an improvement in most of the 
measured parameters, in both a four-week and a three-month period after the therapy. The results show a necessity to carry out fur-
ther randomized control studies of larger groups.
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Streszczenie
Jedną z częściej spotykanych chorób układu nerwowego jest udar mózgu. Do najczęstszych objawów ruchowych należą niedowłady 
bądź porażenia kończyn, z towarzyszącym wzrostem napięcia mięśniowego, zwanym spastycznością. Dla pacjentów oraz ich opiekunów 
zaburzenia te stają się problemem w wielu aspektach życia codziennego, między innymi w lokomocji. Wymaga to poszukiwania 
nowych dróg w tworzeniu terapii mogących zmniejszyć bądź znieść spastyczność i przywrócić zaburzoną funkcję. Terapia toksyną 
botulinową jako metoda obniżająca spastyczność, jest stosowana do tej pory w terapii dzieci z mózgowym porażeniem dziecięcym 
ze stopą końsko-szpotawą i przynosi przełom w leczeniu schorzeń przebiegających z nadmiernym napięciem mięśniowym. Uzysku-
je się poprawę zakresu ruchomości, miedzy innymi w stawie skokowym, a poprzez to ułatwia lokomocję. Poprawa ta uzyskiwana 
jest zarówno poprzez oddziaływanie farmakologiczne, jak i prowadzoną równolegle kinezyterapię. Szczególnie skuteczne wydają się 
metody rehabilitacyjne oparte na mechanizmach neurofizjologicznych. Jedną z takich metod jest PNF. Zastosowanie terapii metodą 
PNF połączone z zastosowaniem toksyny botulinowej u dorosłych wydaje się ułatwiać aktywność ruchową pacjenta po udarze mózgu, 
co może być bardzo ważne w profilaktyce wtórnej udau mózgu. Celem pracy było przedstawienie możliwości połączenia i wpływu 
terapii metodą PNF skojarzoną z podaniem toksyny botulinowej u pacjentów po udarze mózgu ze spastyczną kończyna dolną. Do-
konano w trakcie chodu pomiaru kąta ugięcia w stawie skokowym i kolanowym biorąc pod uwagę amplitudę ruchu, wykorzystując 
system VICON. U wszystkich przebadanych w niniejszym doniesieniu pacjentów odnotowano poprawę większości analizowanych 
parametrów, zarówno w okresie czterotygodniowym, jak i czteromiesięcznym. Przeprowadzone pomiary wskazują na konieczność 
wykonania randomizowanych, kontrolowanych badań na dużych grupach.
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forming this exercise, muscles of 
the lower body part were strength-
ened; balance and coordination of 
pelvic girdle muscles were also ex-
ercised.
3. Combination of shoulder-blade and 
pelvis movement patterns – involv-
ing simultaneous raising the shoul-
der-blade and lowering the pelvis 
on the exercised side. In the second 
phase – the opposite movement is 
performed. This exercise serves as 
a preparation of the patient for the 
alternating effort of the shoulder 
and the pelvic girdles, used during 
gait;
4. From the sitting position on the 
couch, the feet resting on the floor 
– a movement of the body for-
wards, with separation of the but-
tocks from the coach. Therapist’s 
arms initially assisted this move-
ment, however, resisted it subse-
quently, stimulating patient’s anti-
gravitation muscles to a more in-
tensive effort. During returning to 
the sitting position, eccentric inhi-
bition by anti-gravitation muscles 
was exercised.
5. Stabilisation of the erect posture 
by approximation of the iliac crest. 
Therapist’s arms exert a compres-
sion (approximation) to stimulate 
proprioception within the joints of 
the lower extremity, which induc-
es an increased activity of the low-
er limb extensor muscles.
6. Shifting of the body weight during 
taking a step (balance). By load-
ing the paretic extremity, its sta-
bility was trained and thus it was 
getting prepared for its supportive 
role during walking.
7. Walking forwards and backwards 
– by means of this exercise, cor-
rectness of particular gait phases 
was trained in the patient. Appro-
priate resistance exerted by thera-
pist’s arms aided or stimulated the 
effort of the pelvis.
8. Walking on steps. The patient was 
taught to correctly climb the steps, 
which also resulted in a stimulation 
of muscles of the lower limb up to 
the elevation phase and the sup-
porting phase. It is important that 
the therapist constantly secures the 
patient from below.
9. Walking using the tripod – which 
the patient was taught the correct 
support-assisted locomotion with. 
During this exercise, attention 
was paid to a proper movement 
sequence (moving the tripod for-
wards, subsequent step with the pa-
retic limb, finally – a step with the 
non-affected limb). Taking possibly 
greatest advantage of the previous-
ly trained elements is important in 
this activity: loading and moving 
the paretic extremity.
The rehabilitation was conducted by 
certified PNF therapists.
ASSESSMENT METHODS
The movement amplitude of the low-
er extremities and the angular chang-
es in the knee joint and the ankle joint 
occurring during movement were as-
sessed by means of a three-dimensional 
motion capture system VICON 250A.
The VICON 250 system is used for 
spatial measurement and analysis of 
the motion of markers attached to the 
body of the evaluated subject at sites 
corresponding to characteristic bone 
points and joint axes. The device con-
sists of five cameras linked to a com-
puter – database. Each camera emits 
and receives the light of a visible-in-
frared borderline wavelength captur-
ing a flat image of the marker, at a fre-
quency of 120 Hz (possible regulation 
from 60 to 250 Hz). The computer 
generates a three-dimensional image 
and enables analysis of the collected 
study material using appropriate soft-
ware. For the three-dimensional lo-
cation of the markers, each of them 
has to be simultaneously captured by 
at least two cameras. Measurement 
space encompasses the space located 
within the cameras’ fields of view. For 
capturing patients’ gait, the length of 
this space was 10 metres. Each trial 
was repeated three times, both during 
the gait with the elbow crutch and the 
independent gait. The measurements 
were taken during barefoot walking. 
The most accurate of successively per-
formed measurements were used for 
the description of each patient.
The testing procedures began with 
patient’s preparation involving the at-
tachment of the retro-reflective mark-
ers directly onto the skin at the fol-
lowing sites (marker symbols are giv-
en in parentheses):
– on the level of the upper border of 
the sacral bone (SACR),
– on both anterior superior iliac 
spines (LASI and RASI),
– at the lower 1/3, lateral surface of 
the thigh (LTHI and RTHI),
– on the lateral aspect of the rim 
of the knee joint (LKNEE and 
RKNEE),
– at the lower 1/3, lateral surface of 
the tibia (LTIB and RTIB),
– at the level of the ankle (talocrural) 
joint (LANK and RANK),
– at the level of the calcaneal tuber 
(LHEE and RHEE),
– at the level of the first metatarsal 
bone (LTOE and RTOE),
– at the level of the fifth metatarsal 
bone head (LMT5 and RMT5).
The testing was performed three 
times:
– prior to the therapy initiation,
– after termination of the four-week 
therapy,
– three months after therapy termi-
nation.
Given that lower limb spasticity can 
be the main cause of gait disturbanc-
es in the evaluated patients, motion of 
only the following markers: LASI and 
RASI, LKNEE and RKNEE, LANK 
and RANK and LTOE and RTOE, 
used for measurement of angular 
changes occurring during successive 
testing procedures in the ankle and 
knee joints, was subjected to the fi-
nal analysis.
Data analysis was conducted in two 
phases. Preliminary preparation of the 
results and establishing the markers’ 
trajectories were performed using the 
Work Station moduleB. Then, subse-
quent data processing was performed 
using the Body BuilderC software. An-
gular changes were plotted again us-
ing the Work Station programme.
A System Vicon 250 – manufactured by Oxford Metrics Limited, 14 Minns Estate West Way / Minns Business Park West Way, Oxford OX2 0JB, United Kingdom
B Work Station – a system enabling conversion of images from infrared cameras and their presentation in a form of points moving within a space. Manufac-
turer: Oxford Metrics Limited, 14 Minns Estate West Way / Minns Business Park West Way, Oxford OX2 0JB, United Kingdom
C Body Builder – a computer programme enabling creation of mathematical models of human motor system and biomechanical analysis of the data obtained 
using the Work Station system. Oxford Metrics Limited, 14 Minns Estate West Way / Minns Business Park West Way, Oxford OX2 0JB, United Kingdom
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INTRODUCTION
Despite constantly increasing knowl-
edge, cerebrovascular diseases are still 
one of the leading causes of disability 
and also mortality1. The life of a per-
son after stroke, as well as the life of 
his family and closest friends, chang-
es dramatically because of disabili-
ty of various degrees resulting from 
disturbed movement control and al-
tered muscle tone. These phenome-
na, resulting from the upper motor 
neurone lesion, induce impairment 
of gait, development of pathologi-
cal movement patterns and persistent 
contractures and joint deformations. 
Pathologically increased, spastic mus-
cle tone, typical for the paretic (para-
lysed) body side, is present, thus lead-
ing to difficulties in performance of 
activities of daily living, locomotor ac-
tivity, and in an independent self-ser-
vice. Increased muscle tone is also as-
sociated with a more intense activity 
of the non-affected side undertaken to 
compensate for the loss of function. 
Functional problems are associated 
with the following domains: psycho-
logical, intellectual and social, and af-
fect patient’s quality of life to a great-
est extent2,3. The multitude of prob-
lems requires multi-directional thera-
py and rehabilitation.
Physiotherapy is one of the com-
ponents constituting the therapeutic 
process. Its role should involve limi-
tation of movement deficits that oc-
curred in the patient, including basic 
and complex motor functioning and 
self-service4. First of all, physiother-
apy should be directed towards im-
proving patients’ quality of activities 
of daily living and patients’ independ-
ence. Important component of such 
therapy should involve determining, 
in common effort with the patient, 
goals adequate to patient’s abilities 
and current needs. Patients’ problems 
occurring during post-stroke rehabil-
itation, e.g. the dynamics of spasticity 
changes, prompt to modify the ther-
apy being carried out, to search for 
new paths, as well as to combine ther-
apeutic concepts.
The presented case reports refer to 
a problem of combining two methods 
used in neurological rehabilitation – 
kinesitherapy using the PNF meth-
od and application of the botulinum 
toxin. In the presented paper, thera-
py during the late post-stroke period 
is described.
The PNF (Proprioceptive Neu-
romuscular Facilitation) is a method 
used in post-stroke treatment, where 
the functional therapy is a process of 
gradual restitution of patient’s mo-
tor abilities5,6,7. It is a method of neu-
romuscular dysfunction treatment, 
primarily by means of facilitating the 
flow of information, mainly by the 
stimulation of proprioceptors8. Resto-
ration of normal movement based on 
movement patterns, basic principles 
and techniques is directed towards 
normalisation of muscle tone9.
Botulinum toxin therapy is a new 
pharmacological approach used in the 
treatment of spasticity. It is a method 
enabling, via direct effects on the spas-
tic muscle, selective reduction of the 
increased muscle tone without occur-
rence of undesirable effects character-
istic for oral myorelaxants. Botulinum 
toxin is frequently used in the thera-
py of children with cerebral palsy with 
talipes equinovarus10,11; however, it is 
more and more frequently applied in 
the adults in the treatment of diseas-
es with muscular hypertonia12,13,14,15. 
In particular, persons in the late post-
stroke period, with increasing mus-
cle tone, require a search for both 
pharmacologic and physiotherapeu-
tic methods16 that can help to elimi-
nate the strategy of compensation by 
the non-affected side and facilitate the 
functional rehabilitation of the paret-
ic side. Reduction of spasticity in the 
foot and calf is an important domain 
of spasticity treatment in the adults17. 
The aim of botulinum toxin therapy is 
to achieve the improvement in quali-
tative parameters of gait by the elimi-
nation of pathological patterns18.
One of possible modifications of 
the rehabilitation programme in the 
late post-stroke period is a combina-
tion of the PNF method with botu-
linum toxin therapy. Periodic reduc-
tion of muscle tone, resulting from the 
application of the preparation, should 
make the performance of motor ex-
ercises and tasks and maintenance of 
therapy effects easier for the therapist 
and the patient, and help in restora-
tion of the correct movement pattern. 
The achievement of these goals may 
have a significant influence on the re-
duction of patient’s problems in func-
tioning.
Although theoretical premises for 
the combination of the PNF method 
with botulinum toxin application in 
the rehabilitation of post-stroke pa-
tients do exist, the information per-
taining to the efficacy of such therapy 
is lacking in the literature on this top-
ic. There are no descriptions of such 
management either.
In this study, cases of rehabilitation 
of four post-stroke patients are pre-
sented. In two of them, the PNF ther-
apy with botulinum toxin application 
into the spastic muscles of the lower 
extremity was conducted, and in an-
other two patients, the PNF method 
was used without concomitant botu-
linum toxin application.
REHABILITATION CONDUCTED 
ACCORDING TO THE PNF 
CONCEPT
Kinesitherapy in all four patients com-
prised a period of four weeks. The re-
habilitation programme in each pa-
tient included exercises performed for 
45 minutes 5 times a week. All per-
sons came for the exercises indepen-
dently, as outpatients.
The rehabilitation was conducted 
individually and adjusted to current 
needs and abilities of each of the pa-
tients. The therapeutic regime was the 
same for all participants.
It comprised the following elements 
(Table 1):
– initial position,
– basic principles,
– techniques,
– movement patterns.
The rehabilitation also included the 
introduction of additional activities 
such as:
1. Stabilisation of the sitting position 
– using the “feedback stabilisation” 
technique; trunk muscles responsi-
ble for the maintenance of the body 
in vertical position were stimulated 
and strengthened;
2. Asymmetrical movements of the 
pelvis back and forward, in the sit-
ting position – the so-called “walk-
ing on buttocks”, where the patient 
approaches the edge of the couch 
and then moves backwards. By per-
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Table 1
Elements of therapy conducted by PNF method
Initial position Basic principles Techniques Movement patterns
1. lying on the healthy 
side
– manual contact
– verbal contact
– manual resistance
– movement patterns
– rhythmic movement initia-
tion
– posterior lowering of the scapula
– anterior lowering of the pelvis
2. supine – manual contact
– verbal contact
– manual resistance
– movement patterns
– rhythmic movement initia-
tion
– flexion, abduction, external rotation 
(upper limb)
– extension, abduction, external rotation 
(upper limb)
3. supine – manual contact
– verbal contact
– visual contact
– manual resistance
– irradiation
– movement patterns
– diagonal movement
– movement reproduction – flexion, abduction, external rotation 
(upper limb)
– extension, abduction, external rotation 
(upper limb)
4. lying on the healthy 
side
– manual contact
– verbal contact
– visual contact
– manual resistance
– irradiation
– movement patterns
– diagonal movement
– movement reproduction – posterior lowering of the scapula
– anterior lowering of the pelvis
5. supine – summation of stimuli
– manual resistance
– movement patterns
– combination of isotonic 
contractions
– flexion, abduction, external rotation 
(upper limb)
– extension, abduction, external rotation 
(upper limb)
6. lying on the healthy 
side
– summation of stimuli
– manual resistance
– movement patterns
– combination of isotonic 
contractions
– posterior lowering of the scapula
– anterior lowering of the pelvis
7. supine – manual contact
– verbal contact
– manual resistance
– movement patterns
– rhythmic movement initia-
tion
– flexion, abduction, internal rotation 
(lower limb)
– extension, abduction, internal rotation 
(lower limb)
8. supine – manual contact
– verbal contact
– manual resistance
– movement patterns
– movement reproduction – flexion, abduction, internal rotation 
(lower limb)
– extension, abduction, internal rotation 
(lower limb)
9. supine – manual contact
– verbal contact
– manual resistance
– movement patterns
– change of normal move-
ment sequence
– combination of isotonic 
contractions
– flexion, abduction, internal rotation 
(lower limb) (emphasizing the effort of 
the foot using stronger components)
– extension, abduction, internal rotation 
(lower limb) (foot effort reversal)
10. sitting on a chair 
or couch
– manual contact
– verbal contact
– manual resistance
– irradiation
– combination of isotonic 
contractions
– flexion, abduction, external rotation 
(upper limb)
– extension, abduction, external rotation 
(upper limb)
11. sitting on a chair 
or couch
– manual contact
– verbal contact
– approximation
– manual resistance
– feedback stabilisation – maintenance of the correct sitting 
position
– emphasizing scapular and pelvic 
patterns exercised in a low position 
12. standing – approximation
– manual resistance
– visual contact
– rhythmic movement initia-
tion
– movement reproduction
– learning to transfer from the sitting to 
standing position
13. standing – approximation
– manual resistance
– visual contact
– feedback stabilisation – exercises performed in order to 
emphasise the correct position 
assumed by the patient
14. standing – manual contact
– verbal contact
– visual contact
– manual resistance
– irradiation
– summation of stimuli
– rhythmic movement initia-
tion
– movement reproduction
– learning to move the limb up during 
walking
– learning to load the limb during walking
15. standing – manual contact
– verbal contact
– approximation
– manual resistance
– feedback stabilisation – learning to stably load the affected limb 
(primarily during the phase of full load.)
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CASE REPORTS
Patient 1
A 60-year old man had a history of 
left hemisphere intracerebral haem-
orrhage. Non-systematically treat-
ed arterial hypertension had been re-
ported previously. Early rehabilitation 
was started in the neurological ward 
on the 2nd day after the disease on-
set. Prior to the initiation of, during 
and after the four-week PNF + botu-
linum toxin therapy programme, the 
patient attended another rehabilita-
tion centre, where physiotherapy was 
conducted by means of standard reha-
bilitation methods (active exercises of 
the lower limbs, active exercises dur-
ing upper right and lower right limbs 
relief, active-passive exercises of the 
upper right extremity, exercises of the 
lower limbs using the rotor).
The rehabilitation according to the 
PNF concept with concomitant botu-
linum toxin application was conduct-
ed 1.5 years after the haemorrhagic 
stroke. Neurological examination per-
formed before the four-week therapy 
revealed:
– right-sided spastic hemiparesis and 
the talipes equinovarus,
– right upper limb paresis of large de-
gree,
– moderate right lower limb paresis,
– right-sided central facial weak-
ness,
– slight sensorimotor aphasia,
– right lower limb spasticity within 
plantar flexors of the foot – grade 3 
in the modified Ashworth scale19.
The patient was independent; how-
ever, gait disturbances were present 
– the patient complained about prob-
lems with walking up and down the 
stairway. Sporadically, he used the el-
bow crotch.
Botulinum toxin was given with the 
aid of electromyographic identifica-
tion of muscles’ motor points. A to-
tal of 1500 units of Dysport were ad-
ministered. The preparation was ap-
plied into the following muscles: gas-
trocnemius – 1000 units (4 injections), 
tibialis posterior – 300 units (2 injec-
tions), tibialis anterior – 200 units (2 
injections). The patient received the 
BTX A for the first time in his life. 
No undesirable effects occurred. The 
relaxation effect was maintained for 
four months following administration 
of the medicinal product. The reha-
bilitation was started on the follow-
ing day after botulinum toxin appli-
cation. During the four-week kinesi-
therapy, a slight decrease in the paretic 
lower limb muscle tone was observed 
beginning with the 8th day of exer-
cises, which enabled performance of 
the planned motor tasks with a great-
er range of motion. An improvement 
in patient’s gait, both on a flat sur-
face and on a stairway was observed. 
The patient began trials of walking on 
a stairway with an alternating gait.
Results of the testing
Knee joint range of motion (Figure 1)
In the first testing, performed before 
therapy initiation, the amplitude of 
angular changes in the joint was:
– 32.9˚ (50.6% of the physiological 
range of motion during gait) dur-
ing unsupported gait,
– 30.0˚ (46.2% of the physiological 
range of motion during gait) dur-
ing supported gait,
These results indicate a significant re-
duction of the active movement in the 
knee joint.
In the second testing, the amplitude 
of angular changes was:
– 39.0˚ (60% of the physiological 
range of motion during gait) dur-
ing unsupported gait – an increase 
by 18.5% as compared to the first 
testing,
– 41.1˚ (63.2% of the physiological 
range of motion during gait) during 
supported gait – an increase by 37% 
as compared to the first testing.
Use of the combined therapy was 
therefore associated with an improve-
ment in the range of motion.
In the third testing, further increase 
in the amplitude of angular changes 
was observed:
– 42.4˚ (65.2% of the physiological 
range of motion during gait) dur-
ing unsupported gait – an increase 
by 9.5% as compared to the second 
testing and by 28.7% in compari-
son to the first testing,
– 45.0˚ (69.2% of the physiological 
range of motion during gait) dur-
ing supported gait – an increase by 
9.5% as compared to the second 
testing and by 50% in comparison 
to the first testing.
During capturing the unsupported gait, 
the patient showed great hesitation 
during moving the limb up, where-
as using the elbow crotch support al-
lowed the patient to move according to 
the learned motion pattern.
Ankle joint range of motion (Figure 2)
In the first testing, performed before 
therapy initiation, the amplitude of 
angular changes in the joint was:
– 18˚ (60% of the physiological 
range of motion during gait) dur-
ing unsupported gait,
Figure 1
Results of measurements based on amplitude of angular changes in knee joint – Patient 1
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– 18.4˚ (61.3% of the physiological 
range of motion during gait) dur-
ing supported gait.
In the second testing, the amplitude of 
angular changes was:
– 19.1˚ (63.7% of the physiological 
range of motion during gait) during 
unsupported gait – an increase by 
6.1% as compared to the first test-
ing,
– 21.6˚ (72% of the physiological 
range of motion during gait) dur-
ing supported gait – an increase 
by 17.4% as compared to the first 
testing.
Use of the therapy was associated with 
a slight improvement in the range of 
motion.
In the third testing, further increase 
in the amplitude of angular changes 
was observed:
– 22.3˚ (74.3% of the physiological 
range of motion during gait) during 
unsupported gait – an increase by 
16.8% as compared to the second 
testing and an increase by 23.9% in 
comparison to the first testing,
– 24˚ (80% of the physiological 
range of motion during gait) dur-
ing supported gait – an increase by 
11.1% as compared to the second 
testing and an increase by 30.4% in 
comparison to the first testing.
Patient 2
A 67-year old man had a history of 
ischaemic stroke in the territory of the 
right middle cerebral artery; and a his-
tory of paroxysmal atrial fibrillation, 
prostatic hypertrophy, and glaucoma. 
Early rehabilitation was started in the 
neurological ward on the 2nd day after 
the disease onset. Prior to commenc-
ing the four-week PNF + botulinum 
toxin therapy programme, and after 
its termination, the patient was irreg-
ularly subjected to rehabilitation ac-
cording to standard methods (active 
exercises of the relieved left lower 
limb, exercises of the lower extrem-
ities using the rotor, assisted exercis-
es during upper limbs relief, active-
passive exercises of the paretic limbs). 
During the four weeks of therapy, the 
patient did not have any rehabilitation 
treatment in other centres.
The rehabilitation according to the 
PNF concept with concomitant botu-
linum toxin administration was con-
ducted 2 years after the ischaemic 
stroke. Neurological examination per-
formed before the four-week therapy 
revealed:
– left-sided spastic hemiparesis,
– left upper limb paresis of large de-
gree,
– slight left lower limb paresis with 
talipes equinovarus,
– significant disturbances within the 
shoulder and elbow joints due to 
contractures induced by spasticity 
and pain,
– left lower limb spasticity within plan-
tar flexors of the foot – grade 2.5 in 
the modified Ashworth scale19.
The patient was independent, using 
the elbow crotch during walking. Dur-
ing the maximum limb-loading phase 
of the gait, hyperextension in the knee 
joint was present.
Botulinum toxin was administered 
with electromyography-assisted iden-
tification of muscles’ motor points. 
A total of 1500 units of Dysport were 
administered. The preparation was ap-
plied into the following muscles: gas-
trocnemius – 1000 units (4 injections), 
tibialis posterior – 300 units (2 injec-
tions), tibialis anterior – 200 units (2 
injections). The patient received the 
BTX A for the first time in his life. 
No undesirable effects were present. 
The relaxation effect was maintained 
for four months following administra-
tion of the preparation. The rehabil-
itation was started on the following 
day after botulinum toxin application. 
During the four-week kinesitherapy, 
a slight decrease in spasticity of the 
paretic lower limb was observed be-
ginning with the 12th day of exercises. 
The dorsal flexion of the paretic foot 
was facilitated. Patient’s gait was im-
proved both on a flat surface and on 
a stairway. The hyperextension of the 
paretic limb in the knee joint was still 
present during the maximum limb-
loading phase.
Results of the testing
Knee joint range of motion (Figure 3)
In the first testing, performed before 
therapy initiation, the amplitude of 
angular changes in the joint was:
– 28.8˚ (44.3% of the physiological 
range of motion during gait) dur-
ing unsupported gait,
– 24.8˚ (38.2% of the physiological 
range of motion during gait) dur-
ing supported gait,
The results indicate a significant re-
duction of the active movement in the 
knee joint.
In the second testing, the amplitude 
of angular changes was:
– 31.6˚ (48.6% of the physiological 
range of motion during gait) dur-
ing unsupported gait – an increase by 
9.7% as compared to the first testing,
– 29.2˚ (44.9% of the physiological 
range of motion during gait) dur-
ing supported gait – an increase 
by 17.7% as compared to the first 
testing
During the therapy, gait-associated 
motion range improved.
Figure 2
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In the third testing, further increase 
in the amplitude of angular changes 
was observed:
– 37.8˚ (58.2% of the physiological 
range of motion during gait) during 
unsupported gait – an increase by 
19.6% as compared to the second 
testing and an increase by 31.3% in 
comparison to the first testing,
– 29.7˚ (45.7% of the physiological 
range of motion during gait) dur-
ing supported gait – an increase by 
1.7% as compared to the second 
testing and an increase by 19.8% 
in comparison to the first testing.
Ankle joint range of motion (Figure 4)
In the first testing, performed before 
therapy initiation, the amplitude of 
angular changes in the joint was:
– 13.7˚ (45.7% of the physiological 
range of motion during gait) dur-
ing unsupported gait,
– 15.5˚ (51.7% of the physiological 
range of motion during gait) dur-
ing supported gait.
In the second testing, the amplitude of 
angular changes was:
– 15.3˚ (51% of the physiological 
range of motion during gait) dur-
ing unsupported gait – an increase 
by 11.7% as compared to the first 
testing,
– 14.9˚ (49.7% of the physiological 
range of motion during gait) dur-
ing supported gait – a decrease by 
3.9% as compared to the first test-
ing.
In the third testing, a significant in-
crease in the amplitude of angular 
changes was observed:
– 19.4˚ (64.7% of the physiological 
range of motion during gait) during 
unsupported gait – an increase by 
26.8% as compared to the second 
testing and an increase by 41.6% in 
comparison to the first testing,
– 24.6˚ (82% of the physiological 
range of motion during gait) dur-
ing supported gait – an increase by 
65.1% as compared to the second 
testing and an increase by 58.7% in 
comparison to the first testing.
Patient 3
A 67-year old man had a history of 
ischaemic stroke in the territory of 
the right middle cerebral artery; and 
a history of paroxysmal atrial fibrilla-
tion and arterial hypertension. Reha-
bilitation was started in the neurolog-
ical ward on the 1st day of the disease. 
Prior to the initiation of the four-week 
PNF therapy, the patient had physio-
therapy in a rehabilitation ward (a 
four-week hospitalisation) accord-
ing to standard rehabilitation meth-
ods (self-assisted exercises, exercis-
es during relief, passive exercises, ac-
tive-passive exercises, learning to walk 
with the tripod), and subsequently, he 
had a periodic rehabilitation accord-
ing to the PNF concept conducted at 
patient’s home. After termination of 
the four-week therapy, the rehabilita-
tion was continued at patient’s home 
according to the principles of the PNF 
method. During the four weeks of the 
therapy, the patient did not attend 
other rehabilitation centres.
The four-week PNF rehabilitation 
cycle was started 9 months after the 
ischaemic stroke. Botulinum toxin 
was not used. Neurological examina-
tion before the initiation of the four-
week therapy revealed:
– left-sided spastic hemiparesis,
– severe distal spasticity in the left 
upper limb,
Figure 3
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– left upper limb paresis of large de-
gree,
– moderate left lower limb paresis,
– aggravated spasticity within the 
plantar flexors of the toes, particu-
larly during walking,
– left lower limb spasticity within 
plantar flexors of the foot – grade 3 
in the modified Ashworth scale19.
The patient was independent, using 
the elbow crotch during walking.
The foot was secured from drop-
ping by means of the DAFOD device. 
Most pronounced gait disturbanc-
es were observed in the patient dur-
ing the phase of moving the paretic 
limb up.
Results of the testing
Knee joint range of motion (Figure 5)
In the first testing, performed before 
therapy initiation, the amplitude of 
angular changes in the joint was:
– 16.7˚ (25.7% of the physiological 
range of motion during gait) dur-
ing unsupported gait,
– 16.9˚ (26% of the physiological 
range of motion during gait) dur-
ing supported gait.
In the second testing, the amplitude 
of angular changes was:
– 15.5˚ (23.8% of the physiological 
range of motion during gait) during 
unsupported gait – a decrease by 7.2% 
as compared to the first testing,
– 18.3˚ (28.2% of the physiological 
range of motion during gait) during 
supported gait – an increase by 8.3% 
as compared to the first testing.
In the third testing, the amplitude of 
angular changes was:
– 15.7˚ (24.2% of the physiological 
range of motion during gait) dur-
ing unsupported gait – an increase 
by 1.3% as compared to the sec-
ond testing and a decrease by 6% 
in comparison to the first testing,
– 24.9˚ (38.3% of the physiological 
range of motion during gait) dur-
ing supported gait – an increase by 
36.1% as compared to the second 
testing and an increase by 47.3% in 
comparison to the first testing.
Trials performed when the patient 
was using crotch support, demonstrat-
ed the highest increment in the knee 
joint range of motion.
Ankle joint range of motion (Figure 6)
In the first testing, performed before 
therapy initiation, the amplitude of 
angular changes in the joint was:
– 20.5˚ (68.3% of the physiological 
range of motion during gait) dur-
ing unsupported gait,
– 21.9˚ (73% of the physiological 
range of motion during gait) dur-
ing supported gait.
In the second testing, the amplitude of 
angular changes was:
– 16.7˚ (55.7% of the physiological 
range of motion during gait) dur-
ing unsupported gait – a decrease 
by 18.5% as compared to the first 
testing,
– 23.4˚ (78% of the physiological 
range of motion during gait) during 
supported gait – an increase by 6.8% 
as compared to the first testing.
In the third testing, an improvement 
was observed and the amplitude of an-
gular changes was:
– 19.5˚ (65% of the physiological 
range of motion during gait) dur-
ing unsupported gait – an increase 
by 16.8% as compared to the sec-
ond testing and a decrease by 4.9% 
in comparison to the first testing,
– 26˚ (87% of the physiological 
range of motion during gait) dur-
ing supported gait – an increase by 
11.1% as compared to the second 
testing and an increase by 18.7% in 
comparison to the first testing.
D DAFO device – a polypropylene shell preventing foot drop, used as a shoe insert
Figure 5
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Patient 4
A 43-year old man with a history of 
surgery due to a DNT (dysembryo-
blastic neuroepithelial tumour) brain 
tumour of the left temporal lobe, com-
plicated by an ischaemic stroke in the 
territory of the left anterior choroid 
artery. He also had a history of com-
plex partial seizures. Early rehabilita-
tion was started in a hospital ward on 
the 1st day of the disease. Rehabilita-
tion was conducted according to the 
NDT-Bobath and the PNF concepts. 
Prior to commencing the four-week 
PNF therapy programme, the patient 
had had physiotherapy in a private re-
habilitation office 3 times a week ac-
cording to the PNF concept. After 
termination of the four-week thera-
py, the rehabilitation was continued 
in a rehabilitation ward and in an out-
patient clinic. During this period of 
time, elements of the PNF and classi-
cal methods (exercises in relief, self-as-
sisted exercises, active-passive exercis-
es, manipulation exercises of the up-
per extremity) were used in the thera-
py. During the four weeks of the ther-
apy, the patient did not have rehabili-
tation in other centres.
The four-week cycle of the PNF re-
habilitation was started 6 months after 
the ischaemic stroke. Botulinum toxin 
was not used. Neurological examina-
tion performed before the initiation of 
the four-week therapy revealed:
– right-sided spastic hemiparesis,
– moderate paresis of the upper 
limb,
– voluntary movement attempt-induced 
spasticity aggravation in the hand,
– slight paresis of the lower limb,
– right lower limb spasticity within 
plantar flexors of the foot – grade 2 
in the modified Ashworth scale19.
The patient was hardly able to dorsi-
flex his paretic foot. Periodically, he re-
ported occurrence of increased spas-
ticity within the plantar flexors of the 
foot. He was able to walk independent-
ly. When assisted by an accompanying 
person, the patient was able to walk on 
a stairway with an alternating gait. Hy-
perlordosis was observed during gait, 
and excessive flexion of the paretic limb 
in the knee joint was seen during the 
maximum limb-loading phase.
During the measurements, the pa-
tient was moving without the crotch 
all the time.
Results of the testing
Knee joint range of motion (Figure 7)
In the first testing, performed before 
therapy initiation, the amplitude of 
angular changes in the joint was:
– 18.7˚ (28.8% of the physiological 
range of motion during gait) dur-
ing unsupported gait.
In the second testing, the amplitude of 
angular changes was:
– 24.5˚ (37.7% of the physiological 
range of motion during gait) during 
unsupported gait – an increase by 
31% as compared to the first testing.
In the third testing, further improve-
ment of the motion range was ob-
served:
– 28.1˚ (43.2% of the physiological 
range of motion during gait) during 
unsupported gait – an increase by 
14.7% as compared to the second 
testing and an increase by 50.3% in 
comparison to the first testing.
Ankle joint range of motion (Figure 8)
In the first testing, performed before 
therapy initiation, the amplitude of 
angular changes in the joint was:
– 25.9˚ (86.3% of the physiological 
range of motion during gait) dur-
ing unsupported gait.
– 21.9˚ (73% of the physiological 
range of motion during gait) dur-
ing supported gait.
In the second testing, the amplitude of 
angular changes did not change signif-
icantly in comparison to the previous 
measurement and was:
– 25.4˚ (84.7% of the physiological 
range of motion during gait) dur-
ing unsupported gait – a decrease 
by 1.9% as compared to the first 
testing.
In the third testing, the amplitude of 
angular changes was:
– 30.5˚ (102% of the physiological 
range of motion during gait) during 
unsupported gait – an increase by 
20.5% as compared to the second 
testing and an increase by 18.1% in 
comparison to the first testing,
DISCUSSION
During the therapy, re-education 
of patients’ gait was especially em-
phasised. Using the PNF method, 
an attempt was made to achieve the 
planned effect via a reduction of spas-
ticity and an improvement in move-
ment coordination. Additionally, two 
patients were given botulinum tox-
in injections. In the conducted eval-
uations, we tried to determine sim-
ple markers that could enable esti-
mation of therapy effectiveness both 
immediately after termination of re-
habilitation and after a longer peri-
od of time following particular ther-
apeutic actions. The recorded chang-
es in the range of motion in the lower 
limb joints during walking may serve 
as a parameter of gait quality evalua-
tion. It was observed that gait quali-
ty expressed as amplitude of angular 
changes in the knee and ankle joints, 
obtained during the four-week PNF 
Figure 7, 8
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therapy programme, was maintained 
on a similar level or increased during 
3 months following the therapy. This 
may be indicative of an educational 
effect of the conducted rehabilitation, 
thanks to which patients were able to 
introduce the skills learnt during the 
programme to their every-day activi-
ties thus achieving an improvement in 
their locomotion.
In other studies5,20,21,22, improve-
ment of gait was demonstrated by 
means of such factors as gait speed, 
relative step length or symmetry in-
dex, apart from the angular changes in 
the articulations. In this study, to esti-
mate patient’s functional disturbances 
and to assess the effects of the meth-
ods aimed at reducing muscle tone 
and improving coordination, we fo-
cused on the quality and correctness 
of gait mechanics, whereas gait veloc-
ity and step length receded into the 
background. The elbow crotch-sup-
ported gait was also compared to the 
unsupported gait because of a possi-
ble influence of pathological motion 
patterns, occurring with a greater ac-
tivity of the non-affected side, on pa-
tient’s locomotion.
For a more complete picture of 
changes occurring as a result of the 
PNF therapy and the combined ther-
apy with concomitant botulinum tox-
in injection, other markers of patients’ 
functional status, such as e.g. the Bar-
thel index, as well as muscle tone 
scales such as the modified Ashworth 
scale10,19,23 should also be considered.
In this study, a possibility of com-
bining the botulinum toxin and the 
PNF therapies was presented. Nor-
mal course of patients’ rehabilita-
tion process and a gradual improve-
ment in the range of motion in the 
knee and ankle joints was present-
ed. There were no marked differenc-
es across the case reports. Unequivo-
cal effects of the combination of the 
methods were not observed. Theo-
retical data allow assumption that the 
combination of botulinum toxin ad-
ministration and the PNF method is 
a plausible management9,12,13. Applica-
tion of the combined therapies is sup-
posed to facilitate patient’s and thera-
pist’s efforts towards the re-education 
of the lost motor function via a tem-
porary reduction in spasticity. Expec-
tations associated with the combina-
tion of these therapies include mainly 
the possibility to maintain and con-
solidate the effect of rehabilitation in-
volving reproduction of normal mo-
tion patterns, reduction of patholog-
ical movements induced by spasticity 
of the paretic limbs, and an improve-
ment in patients’ quality of life by re-
ducing disturbances of functioning.
As there are no clinical studies on 
the effects of the combined PNF and 
botulinum toxin therapy on the adult 
post-stroke patients’ rehabilitation 
process, in the future, it is necessary 
to plan large, randomised, controlled 
clinical studies, comparing patients 
subjected to the PNF method with pa-
tients in a similar neurological state 
treated with the botulinum toxin, and 
the patients, in whom both methods 
were used concomitantly. Clinical tri-
als, conducted according to the above 
assumptions, can allow unequivocal 
evaluation of and drawing conclu-
sions from such therapy, as well as 
determine a rehabilitation model that 
would be of use in comprehensive 
therapy of stroke sequelae.
Based on the reported cases, con-
clusions regarding the efficacy of the 
combined PNF and botulinum toxin 
therapy cannot be drawn; however, 
the performed observations may fa-
cilitate planning clinical studies on the 
effects of these methods on the reha-
bilitation process during the late post-
stroke period.
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